Barinthus Biotherapeutics plc (BRNS) Misses Q2 EPS by 16c

Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q2 EPS of ($0.52), $0.16 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.

You May Also Be Interested In

• Subaru, other Japan suppliers to team on delivery as Boeing raises output - Nikkei
• Samsara Inc (IOT) call put ratio 4.5 calls to 1 put with a focus on September 4 weekly calls into quarter results
• Lands' End (LE) Tops Q2 EPS by 1c